Co-Diagnostics Inc. [NASDAQ: CODX] loss -1.91% or -0.3 points to close at $15.43 with a heavy trading volume of 3980706 shares. The company report on August 17, 2020 that The Gross Law Firm Announces Class Actions on Behalf of Shareholders of USO, CODX and GEO.
NEW YORK, NY / ACCESSWIRE / August 17, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.
United States Oil Fund, LP (NYSE:USO).
It opened the trading session at $15.55, the shares rose to $16.1299 and dropped to $14.92, the range by which the price of stock traded the whole day. The daily chart for CODX points out that the company has recorded 412.46% gains over the past six months. However, it is still -1715.29% lower than its most recent low trading price.
If we look at the average trading volume of 3.48M shares, CODX reached to a volume of 3980706 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Co-Diagnostics Inc. [CODX]:
Maxim Group have made an estimate for Co-Diagnostics Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 20, 2020. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price from $20 to $35. The new note on the price target was released on May 18, 2020, representing the official price target for Co-Diagnostics Inc. stock. Previously, the target price had yet another raise from $4 to $20, while H.C. Wainwright kept a Buy rating on CODX stock.
The Average True Range (ATR) for Co-Diagnostics Inc. is set at 2.47, with the Price to Sales ratio for CODX stock in the period of the last 12 months amounting to 21.25. The Price to Book ratio for the last quarter was 12.75, with the Price to Cash per share for the same quarter was set at 0.53.
Trading performance analysis for CODX stock
Co-Diagnostics Inc. [CODX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -33.66. With this latest performance, CODX shares dropped by -18.69% in over the last four-week period, additionally plugging by 412.46% over the last 6 months – not to mention a rise of 1232.27% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CODX stock in for the last two-week period is set at 35.72, with the RSI for the last a single of trading hit 28.81, and the three-weeks RSI is set at 40.13 for Co-Diagnostics Inc. [CODX]. The present Moving Average for the last 50 days of trading for this stock 19.73, while it was recorded at 17.60 for the last single week of trading, and 10.35 for the last 200 days.
Co-Diagnostics Inc. [CODX]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Co-Diagnostics Inc. [CODX] shares currently have an operating margin of -2741.61 and a Gross Margin at +17.04. Co-Diagnostics Inc.’s Net Margin is presently recorded at -2882.00.
Return on Total Capital for CODX is now -455.64, given the latest momentum, and Return on Invested Capital for the company is -1,826.40. Return on Equity for this stock declined to -1,826.40, with Return on Assets sitting at -328.81.
Reflecting on the efficiency of the workforce at the company, Co-Diagnostics Inc. [CODX] managed to generate an average of -$269,372 per employee. Receivables Turnover for the company is 2.97 with a Total Asset Turnover recorded at a value of 0.11.Co-Diagnostics Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.20 and a Current Ratio set at 11.60.
Co-Diagnostics Inc. [CODX]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Co-Diagnostics Inc. posted -0.1/share EPS, while the average EPS was predicted by analysts to be reported at -0.07/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -42.90%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CODX.
An analysis of insider ownership at Co-Diagnostics Inc. [CODX]
There are presently around $103 million, or 20.30% of CODX stock, in the hands of institutional investors. The top three institutional holders of CODX stocks are: BLACKROCK INC. with ownership of 1,801,790, which is approximately New of the company’s market cap and around 24.21% of the total institutional ownership; VANGUARD GROUP INC, holding 1,302,263 shares of the stock with an approximate value of $20.09 million in CODX stocks shares; and STATE STREET CORP, currently with $7.34 million in CODX stock with ownership of nearly New of the company’s market capitalization.
Positions in Co-Diagnostics Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 69 institutional holders increased their position in Co-Diagnostics Inc. [NASDAQ:CODX] by around 4,986,283 shares. Additionally, 20 investors decreased positions by around 476,629 shares, while 6 investors held positions by with 1,216,765 shares. The mentioned changes placed institutional holdings at 6,679,677 shares, according to the latest SEC report filing. CODX stock had 50 new institutional investments in for a total of 3,265,371 shares, while 9 institutional investors sold positions of 191,626 shares during the same period.